皮肤T细胞淋巴瘤的药理管理方面的进展
Gabriele Roccuzzo1, Andrea Roggo2, Egle Ramelyte2
1Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy.
Expert opinion on pharmacotherapy
|June 3, 2024
概括
最近皮肤T细胞淋巴瘤 (CTCL) 治疗的进展为人们带来了新的希望. 本综述详细介绍了过去十年的治疗进展,强调了CTCL管理的持续挑战和未来方向.
科学领域:
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
背景情况:
- 目前的皮肤T细胞淋巴瘤 (CTCL) 治疗指南遵循阶段式方法.
- 对CTCL的治疗选择取决于疾病亚型,严重程度和患者因素,旨在改善生活质量.
研究的目的:
- 审查过去十年 (2013-2023) 中CTCL治疗的关键发展.
- 为临床医生和研究人员提供关于CTCL近期治疗进展的全面视角.
主要方法:
- 对CTCL的创新疗法和传统治疗计划的审查.
- 从2013年到2023年对CTCL疗法的关键发展进行分析.
主要成果:
- 随着新药的引入,CTCL的治疗场景发生了变化.
- 在CTCL的局部化疗药物和免疫调节剂方面取得了进展.
结论:
- 尽管取得了进展,但在CTCL治疗方面仍然存在未得到满足的需求.
- 治疗反应的预测因素,了解瘤微环境和组合疗法需要进一步调查以优化CTCL治疗.
相关概念视频
Tumor Immunotherapy
514
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
514
Inflammatory Bowel Disease IV: Pharmacological Management
126
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
126
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
157
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
157


![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)